ChristopherCarrollSmith

Biogen - opportunity to get in at the bottom

Pembelian
NASDAQ:BIIB   Biogen Inc.
After a recent downward gap, BIIB looks to me to have established a new upward channel. With bullish MACD, great analyst ratings, a history of earnings beats, and the next earnings coming up in mid-July, BIIB should be up in the short-to-medium term. Set fairly tight stops to protect against a downward channel breakout.

Here's my Biogen trading plan Monday morning:

Limit buy 238.17
Stop Loss: 231
Take profit: 287

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.